theory clinical_107_10
imports Main


begin

typedecl entity
typedecl event

consts
  HER2Mutation :: "entity ⇒ bool"
  V777L :: "entity ⇒ bool"
  Overexpression :: "entity ⇒ event ⇒ bool"
  ResultedIn :: "event ⇒ entity ⇒ bool"
  TrastuzumabResistance :: "entity ⇒ bool"
  By :: "event ⇒ entity ⇒ bool"
  ColonyFormationAssay :: "entity ⇒ bool"
  SoftAgar :: "entity ⇒ bool"
  CancerCellLine :: "entity ⇒ bool"
  Tumours :: "entity ⇒ bool"
  PortionOf :: "entity ⇒ bool"
  Develop :: "event ⇒ entity ⇒ entity ⇒ bool"
  Ultimately :: "event ⇒ bool"
  Resistance :: "entity ⇒ bool"
  To :: "event ⇒ entity ⇒ entity ⇒ bool"
  AntiHER2Therapy :: "entity ⇒ bool"
  Patient :: "entity ⇒ bool"
  Treatment :: "entity ⇒ bool"
  Benefit :: "event ⇒ entity ⇒ entity ⇒ bool"
  From :: "event ⇒ entity ⇒ entity ⇒ bool"
  With :: "event ⇒ entity ⇒ entity ⇒ bool"
  Trastuzumab :: "entity ⇒ bool"

(* Explanation 1: Overexpression of a HER2 V777L mutation resulted in trastuzumab resistance by a soft-agar colony formation assay of a colorectal cancer cell line. *)
axiomatization where
  explanation_1: "∃x y z e. HER2Mutation x ∧ V777L x ∧ Overexpression x e ∧ ResultedIn e y ∧ TrastuzumabResistance y ∧ By e z ∧ ColonyFormationAssay z ∧ SoftAgar z ∧ CancerCellLine z"

(* Explanation 2: A portion of tumours, however, ultimately develop resistance to anti-HER2 antibody therapy. *)
axiomatization where
  explanation_2: "∃x y e. Tumours x ∧ PortionOf x ∧ Develop e x y ∧ Ultimately e ∧ Resistance y ∧ To e y AntiHER2Therapy"

(* Explanation 3: Patient may benefit from treatment with Trastuzumab. *)
axiomatization where
  explanation_3: "∃x y e. Patient x ∧ Treatment y ∧ Benefit e x y ∧ From e x y ∧ With e y Trastuzumab"


theorem hypothesis:
 assumes asm: "Patient x"
  (* Hypothesis: This patient may develop resistance to Trastuzumab therapy. *)
 shows "∃x y e. Patient x ∧ Resistance y ∧ Develop e x y ∧ To e y Trastuzumab"
proof -
  (* From the premise, we know that the patient is x. *)
  from asm have "Patient x" <ATP>
  (* There is a logical relation Implies(A, C), Implies(overexpression of a HER2 V777L mutation resulted in trastuzumab resistance by a soft-agar colony formation assay of a colorectal cancer cell line, patient may benefit from treatment with Trastuzumab) *)
  (* We can infer that the patient may benefit from treatment with Trastuzumab. *)
  then have "∃x y e. Patient x ∧ Treatment y ∧ Benefit e x y ∧ From e x y ∧ With e y Trastuzumab" <ATP>
  (* There is a logical relation Implies(Not(C), Not(A)), Implies(Not(patient may benefit from treatment with Trastuzumab), Not(overexpression of a HER2 V777L mutation resulted in trastuzumab resistance by a soft-agar colony formation assay of a colorectal cancer cell line)) *)
  (* Since the patient may benefit from treatment with Trastuzumab, we can infer the overexpression of a HER2 V777L mutation resulted in trastuzumab resistance. *)
  then have "∃x y z e. HER2Mutation x ∧ V777L x ∧ Overexpression x e ∧ ResultedIn e y ∧ TrastuzumabResistance y ∧ By e z ∧ ColonyFormationAssay z ∧ SoftAgar z ∧ CancerCellLine z" <ATP>
  (* Combining the above two inferences, we can conclude that the patient may develop resistance to Trastuzumab therapy. *)
  then show ?thesis <ATP>
qed

end
